Latest News

DOD, FDA Partner to Develop Medical Products for Warfighters

January 16, 2018 | US Department of Defense

The Defense Department and Food and Drug Administration have launched a joint pilot program to prioritize efficiently developing safe and effective medical products to save the lives of U.S. warfighters.

EDITOR'S NOTE: One of Expanesthetics' programs may qualify for this DOD/FDA program, post-pilot.

Back to top

Macroeconomic trends in the healthcare sector

December 20, 2017 | Mercia Technologies

Dr. Ash Patel discusses three of the biggest macroeconomic trends in healthcare: an aging population, expanding markets in emerging economies worldwide, and the growth of usable medical databases.

EDITOR'S NOTE: Expanesthetics lies at the intersection of two of these trends.

Back to top

Focus Matters: How Biopharma Can Reward Shareholders

November 30, 2016 | Bain & Company

Large biotech companies have been providing lower total shareholder returns (TSR) when compared to smaller biotech companies, and the reason may be that smaller biotech companies are able to focus on a particular category and better understand the needs and value drivers of that category.

Back to top